SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsMediumNeutral
Announced Tue, 23 Sept · 14:37 IST

Completion of tenure of Dr. Kamal Kishore Sharma as Independent Director of the Company.

Management Changes View source PDF

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Dr. Kamal Kishore Sharma (DIN: 00209430) completed his term as an Independent Director of Shilpa Medicare Limited on September 23, 2025, and ceased to hold the position from the close of business hours that day. He also stepped down as a member of the Audit Committee, Stakeholders Relationship Committee, and Risk Management Committee of the company. The Board placed on record its appreciation for his contributions during his tenure. This is a routine end-of-term event and not a resignation or removal.

Likely market impact

This is a scheduled end of tenure and unlikely to materially affect the stock. Investors may want to watch for a replacement Independent Director appointment in due course, as the board will need to fill the vacancy to maintain required composition under SEBI rules.